Cargando…
Utilization of COVID-19 allografts without transmission to recipients in liver transplantation
Autores principales: | Whitrock, J., Quillin, R., Delman, A., Price, A., Sharma, D., Wang, J., Lemon, K., Chang, A., Silski, L., Cuffy, M., Shah, S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Ltd.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10279482/ http://dx.doi.org/10.1016/j.hpb.2023.05.094 |
Ejemplares similares
-
Keeping the lights on: Telehealth, testing, and 6-month outcomes for orthotopic liver transplantation during the COVID-19 pandemic
por: Delman, Aaron M., et al.
Publicado: (2021) -
Through thick and thin: Risk of venous thromboembolism vs bleeding after abdominal transplant
por: Whitrock, Jenna N., et al.
Publicado: (2023) -
Immune checkpoint inhibitors in liver transplant: a case series
por: Rudolph, Mark, et al.
Publicado: (2023) -
Causes of death in renal transplant recipients with functioning allograft
por: Prakash, J., et al.
Publicado: (2012) -
Cardiac allograft vasculopathy in Dutch heart transplant recipients
por: Galli, G., et al.
Publicado: (2016)